Operating Lease, Right-of-Use Asset of Astria Therapeutics, Inc. from 30 Sep 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Astria Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Sep 2019 to 30 Sep 2025.
  • Astria Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $4,254,000, a 21% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Astria Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,254,000 -$1,136,000 -21% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $4,546,000 -$1,169,000 -20% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $4,833,000 +$4,623,000 +2201% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $5,114,000 +$4,751,000 +1309% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $5,390,000 +$4,876,000 +949% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $5,715,000 +$5,054,000 +765% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $210,000 -$596,000 -74% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $363,000 -$585,000 -62% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 $514,000 -$573,000 -53% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $661,000 -$621,000 -48% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $806,000 +$578,000 +254% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $948,000 +$554,000 +141% 31 Dec 2022 10-K 04 Mar 2024 2023 FY
Q3 2022 $1,087,000 +$530,000 +95% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $1,282,000 +$565,000 +79% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $228,000 -$646,000 -74% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $394,000 -$572,000 -59% 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 $557,000 -$621,000 -53% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $717,000 -$609,000 -46% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $874,000 -$925,000 -51% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $966,000 -$1,383,000 -59% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 $1,178,000 +$213,000 +22% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $1,326,000 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $1,799,000 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 $2,349,000 31 Dec 2019 10-K/A 19 Apr 2021 2020 FY
Q3 2019 $965,000 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.